These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12805489)

  • 1. UK-279,276, a neutrophil inhibitory glycoprotein, in acute stroke: tolerability and pharmacokinetics.
    Lees KR; Diener HC; Asplund K; Krams M;
    Stroke; 2003 Jul; 34(7):1704-9. PubMed ID: 12805489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke.
    Krams M; Lees KR; Hacke W; Grieve AP; Orgogozo JM; Ford GA;
    Stroke; 2003 Nov; 34(11):2543-8. PubMed ID: 14563972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, Pharmacokinetics and Pharmacodynamics of TNHH, a Novel Targeted Neutrophil-Inhibitory Hirulog Hybrid Glycoprotein, in Healthy Volunteers.
    Gou ZP; Song ZH; Chen XG; Hu XC; Wang Y; Fan K; Cai YM; Zheng L
    CNS Drugs; 2019 Jun; 33(6):605-614. PubMed ID: 31093952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke.
    Lees KR; Sharma AK; Barer D; Ford GA; Kostulas V; Cheng YF; Odergren T
    Stroke; 2001 Mar; 32(3):675-80. PubMed ID: 11239186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
    Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
    J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen.
    Kaste M; Murayama S; Ford GA; Dippel DW; Walters MR; Tatlisumak T;
    Cerebrovasc Dis; 2013; 36(3):196-204. PubMed ID: 24135530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging the pharmacokinetics and pharmacodynamics of UK-279,276 across healthy volunteers and stroke patients using a mechanistically based model for target-mediated disposition.
    Jonsson EN; Macintyre F; James I; Krams M; Marshall S
    Pharm Res; 2005 Aug; 22(8):1236-46. PubMed ID: 16078133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.
    Lees KR; Barer D; Ford GA; Hacke W; Kostulas V; Sharma AK; Odergren T;
    Stroke; 2003 Feb; 34(2):482-7. PubMed ID: 12574564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.
    Schäbitz WR; Laage R; Vogt G; Koch W; Kollmar R; Schwab S; Schneider D; Hamann GF; Rosenkranz M; Veltkamp R; Fiebach JB; Hacke W; Grotta JC; Fisher M; Schneider A
    Stroke; 2010 Nov; 41(11):2545-51. PubMed ID: 20947859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results.
    Ginsberg MD; Hill MD; Palesch YY; Ryckborst KJ; Tamariz D
    Stroke; 2006 Aug; 37(8):2100-6. PubMed ID: 16809571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
    Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
    Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
    Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W;
    Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
    Piriyawat P; Labiche LA; Burgin WS; Aronowski JA; Grotta JC
    Stroke; 2003 May; 34(5):1242-5. PubMed ID: 12690224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.
    Lees KR; Bornstein N; Diener HC; Gorelick PB; Rosenberg G; Shuaib A;
    Stroke; 2013 Mar; 44(3):580-4. PubMed ID: 23391764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial).
    Cramer SC; Hill MD;
    Int J Stroke; 2014 Apr; 9(3):321-7. PubMed ID: 24588854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of the low-affinity, use-dependent NMDA antagonist AR-R15896AR in stroke patients: a dose-ranging study.
    Lees KR; Dyker AG; Sharma A; Ford GA; Ardron ME; Grosset DG
    Stroke; 2001 Feb; 32(2):466-72. PubMed ID: 11157184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
    Palesch YY; Hill MD; Ryckborst KJ; Tamariz D; Ginsberg MD
    Stroke; 2006 Aug; 37(8):2107-14. PubMed ID: 16809570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.